IGM Biosciences, Inc.
IgM Fc and J-chain mutations that affect IgM serum half-life
Last updated:
Abstract:
This disclosure provides an IgM antibody or IgM-like antibody comprising a variant J-chain and/or variant IgM heavy chain constant regions that can confer increased serum half-life upon the antibody.
Status:
Grant
Type:
Utility
Filling date:
23 Mar 2020
Issue date:
26 Jan 2021